Functional selectivity and time‐dependence of μ‐opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area

Background and Purpose The majority of studies examining desensitization of the μ‐opioid receptor (MOR) have examined those located at cell bodies. However, MORs are extensively expressed at nerve terminals throughout the mammalian nervous system. This study is designed to investigate agonist‐induce...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of pharmacology Vol. 172; no. 2; pp. 469 - 481
Main Authors Lowe, J D, Bailey, C P
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background and Purpose The majority of studies examining desensitization of the μ‐opioid receptor (MOR) have examined those located at cell bodies. However, MORs are extensively expressed at nerve terminals throughout the mammalian nervous system. This study is designed to investigate agonist‐induced MOR desensitization at nerve terminals in the mouse ventral tegmental area (VTA). Experimental Approach MOR function was measured in mature mouse brain slices containing the VTA using whole‐cell patch‐clamp electrophysiology. Presynaptic MOR function was isolated from postsynaptic function and the functional selectivity, time‐dependence and mechanisms of agonist‐induced MOR desensitization were examined. Key Results MORs located at GABAergic nerve terminals in the VTA were completely resistant to rapid desensitization induced by the high‐efficacy agonists DAMGO and Met‐enkephalin. MORs located postsynaptically on GABAergic cell bodies readily underwent rapid desensitization in response to DAMGO. However, after prolonged (>7 h) treatment with Met‐enkephalin, profound homologous MOR desensitization was observed. Morphine could induce rapid MOR desensitization at nerve terminals when PKC was activated. Conclusions and Implications Agonist‐induced MOR desensitization in GABAergic neurons in the VTA is compartment‐selective as well as agonist‐selective. When MORs are located at cell bodies, higher‐efficacy agonists induce greater levels of rapid desensitization than lower‐efficacy agonists. However, the converse is true at nerve terminals where agonists that induce MOR desensitization via PKC are capable of rapid agonist‐induced desensitization while higher‐efficacy agonists are not. MOR desensitization induced by higher‐efficacy agonists at nerve terminals only takes place after prolonged receptor activation. Linked Articles This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2
AbstractList The majority of studies examining desensitization of the μ-opioid receptor (MOR) have examined those located at cell bodies. However, MORs are extensively expressed at nerve terminals throughout the mammalian nervous system. This study is designed to investigate agonist-induced MOR desensitization at nerve terminals in the mouse ventral tegmental area (VTA). MOR function was measured in mature mouse brain slices containing the VTA using whole-cell patch-clamp electrophysiology. Presynaptic MOR function was isolated from postsynaptic function and the functional selectivity, time-dependence and mechanisms of agonist-induced MOR desensitization were examined. MORs located at GABAergic nerve terminals in the VTA were completely resistant to rapid desensitization induced by the high-efficacy agonists DAMGO and Met-enkephalin. MORs located postsynaptically on GABAergic cell bodies readily underwent rapid desensitization in response to DAMGO. However, after prolonged (>7 h) treatment with Met-enkephalin, profound homologous MOR desensitization was observed. Morphine could induce rapid MOR desensitization at nerve terminals when PKC was activated. Agonist-induced MOR desensitization in GABAergic neurons in the VTA is compartment-selective as well as agonist-selective. When MORs are located at cell bodies, higher-efficacy agonists induce greater levels of rapid desensitization than lower-efficacy agonists. However, the converse is true at nerve terminals where agonists that induce MOR desensitization via PKC are capable of rapid agonist-induced desensitization while higher-efficacy agonists are not. MOR desensitization induced by higher-efficacy agonists at nerve terminals only takes place after prolonged receptor activation. This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.
Background and Purpose The majority of studies examining desensitization of the mu -opioid receptor (MOR) have examined those located at cell bodies. However, MORs are extensively expressed at nerve terminals throughout the mammalian nervous system. This study is designed to investigate agonist-induced MOR desensitization at nerve terminals in the mouse ventral tegmental area (VTA). Experimental Approach MOR function was measured in mature mouse brain slices containing the VTA using whole-cell patch-clamp electrophysiology. Presynaptic MOR function was isolated from postsynaptic function and the functional selectivity, time-dependence and mechanisms of agonist-induced MOR desensitization were examined. Key Results MORs located at GABAergic nerve terminals in the VTA were completely resistant to rapid desensitization induced by the high-efficacy agonists DAMGO and Met-enkephalin. MORs located postsynaptically on GABAergic cell bodies readily underwent rapid desensitization in response to DAMGO. However, after prolonged (>7h) treatment with Met-enkephalin, profound homologous MOR desensitization was observed. Morphine could induce rapid MOR desensitization at nerve terminals when PKC was activated. Conclusions and Implications Agonist-induced MOR desensitization in GABAergic neurons in the VTA is compartment-selective as well as agonist-selective. When MORs are located at cell bodies, higher-efficacy agonists induce greater levels of rapid desensitization than lower-efficacy agonists. However, the converse is true at nerve terminals where agonists that induce MOR desensitization via PKC are capable of rapid agonist-induced desensitization while higher-efficacy agonists are not. MOR desensitization induced by higher-efficacy agonists at nerve terminals only takes place after prolonged receptor activation. Linked Articles This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2
Background and Purpose The majority of studies examining desensitization of the μ‐opioid receptor ( MOR ) have examined those located at cell bodies. However, MOR s are extensively expressed at nerve terminals throughout the mammalian nervous system. This study is designed to investigate agonist‐induced MOR desensitization at nerve terminals in the mouse ventral tegmental area ( VTA ). Experimental Approach MOR function was measured in mature mouse brain slices containing the VTA using whole‐cell patch‐clamp electrophysiology. Presynaptic MOR function was isolated from postsynaptic function and the functional selectivity, time‐dependence and mechanisms of agonist‐induced MOR desensitization were examined. Key Results MOR s located at GABA ergic nerve terminals in the VTA were completely resistant to rapid desensitization induced by the high‐efficacy agonists DAMGO and Met‐enkephalin. MOR s located postsynaptically on GABA ergic cell bodies readily underwent rapid desensitization in response to DAMGO . However, after prolonged (>7 h) treatment with Met‐enkephalin, profound homologous MOR desensitization was observed. Morphine could induce rapid MOR desensitization at nerve terminals when PKC was activated. Conclusions and Implications Agonist‐induced MOR desensitization in GABA ergic neurons in the VTA is compartment‐selective as well as agonist‐selective. When MOR s are located at cell bodies, higher‐efficacy agonists induce greater levels of rapid desensitization than lower‐efficacy agonists. However, the converse is true at nerve terminals where agonists that induce MOR desensitization via PKC are capable of rapid agonist‐induced desensitization while higher‐efficacy agonists are not. MOR desensitization induced by higher‐efficacy agonists at nerve terminals only takes place after prolonged receptor activation. Linked Articles This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2
BACKGROUND AND PURPOSEThe majority of studies examining desensitization of the μ-opioid receptor (MOR) have examined those located at cell bodies. However, MORs are extensively expressed at nerve terminals throughout the mammalian nervous system. This study is designed to investigate agonist-induced MOR desensitization at nerve terminals in the mouse ventral tegmental area (VTA). EXPERIMENTAL APPROACHMOR function was measured in mature mouse brain slices containing the VTA using whole-cell patch-clamp electrophysiology. Presynaptic MOR function was isolated from postsynaptic function and the functional selectivity, time-dependence and mechanisms of agonist-induced MOR desensitization were examined. KEY RESULTSMORs located at GABAergic nerve terminals in the VTA were completely resistant to rapid desensitization induced by the high-efficacy agonists DAMGO and Met-enkephalin. MORs located postsynaptically on GABAergic cell bodies readily underwent rapid desensitization in response to DAMGO. However, after prolonged (>7 h) treatment with Met-enkephalin, profound homologous MOR desensitization was observed. Morphine could induce rapid MOR desensitization at nerve terminals when PKC was activated. CONCLUSIONS AND IMPLICATIONSAgonist-induced MOR desensitization in GABAergic neurons in the VTA is compartment-selective as well as agonist-selective. When MORs are located at cell bodies, higher-efficacy agonists induce greater levels of rapid desensitization than lower-efficacy agonists. However, the converse is true at nerve terminals where agonists that induce MOR desensitization via PKC are capable of rapid agonist-induced desensitization while higher-efficacy agonists are not. MOR desensitization induced by higher-efficacy agonists at nerve terminals only takes place after prolonged receptor activation. LINKED ARTICLESThis article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.
Background and Purpose The majority of studies examining desensitization of the μ‐opioid receptor (MOR) have examined those located at cell bodies. However, MORs are extensively expressed at nerve terminals throughout the mammalian nervous system. This study is designed to investigate agonist‐induced MOR desensitization at nerve terminals in the mouse ventral tegmental area (VTA). Experimental Approach MOR function was measured in mature mouse brain slices containing the VTA using whole‐cell patch‐clamp electrophysiology. Presynaptic MOR function was isolated from postsynaptic function and the functional selectivity, time‐dependence and mechanisms of agonist‐induced MOR desensitization were examined. Key Results MORs located at GABAergic nerve terminals in the VTA were completely resistant to rapid desensitization induced by the high‐efficacy agonists DAMGO and Met‐enkephalin. MORs located postsynaptically on GABAergic cell bodies readily underwent rapid desensitization in response to DAMGO. However, after prolonged (>7 h) treatment with Met‐enkephalin, profound homologous MOR desensitization was observed. Morphine could induce rapid MOR desensitization at nerve terminals when PKC was activated. Conclusions and Implications Agonist‐induced MOR desensitization in GABAergic neurons in the VTA is compartment‐selective as well as agonist‐selective. When MORs are located at cell bodies, higher‐efficacy agonists induce greater levels of rapid desensitization than lower‐efficacy agonists. However, the converse is true at nerve terminals where agonists that induce MOR desensitization via PKC are capable of rapid agonist‐induced desensitization while higher‐efficacy agonists are not. MOR desensitization induced by higher‐efficacy agonists at nerve terminals only takes place after prolonged receptor activation. Linked Articles This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2
Background and Purpose The majority of studies examining desensitization of the µ-opioid receptor (MOR) have examined those located at cell bodies. However, MORs are extensively expressed at nerve terminals throughout the mammalian nervous system. This study is designed to investigate agonist-induced MOR desensitization at nerve terminals in the mouse ventral tegmental area (VTA). Experimental Approach MOR function was measured in mature mouse brain slices containing the VTA using whole-cell patch-clamp electrophysiology. Presynaptic MOR function was isolated from postsynaptic function and the functional selectivity, time-dependence and mechanisms of agonist-induced MOR desensitization were examined. Key Results MORs located at GABAergic nerve terminals in the VTA were completely resistant to rapid desensitization induced by the high-efficacy agonists DAMGO and Met-enkephalin. MORs located postsynaptically on GABAergic cell bodies readily underwent rapid desensitization in response to DAMGO. However, after prolonged (>7h) treatment with Met-enkephalin, profound homologous MOR desensitization was observed. Morphine could induce rapid MOR desensitization at nerve terminals when PKC was activated. Conclusions and Implications Agonist-induced MOR desensitization in GABAergic neurons in the VTA is compartment-selective as well as agonist-selective. When MORs are located at cell bodies, higher-efficacy agonists induce greater levels of rapid desensitization than lower-efficacy agonists. However, the converse is true at nerve terminals where agonists that induce MOR desensitization via PKC are capable of rapid agonist-induced desensitization while higher-efficacy agonists are not. MOR desensitization induced by higher-efficacy agonists at nerve terminals only takes place after prolonged receptor activation. Linked Articles This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2
Author Bailey, C P
Lowe, J D
Author_xml – sequence: 1
  givenname: J D
  surname: Lowe
  fullname: Lowe, J D
  organization: University of Bristol
– sequence: 2
  givenname: C P
  surname: Bailey
  fullname: Bailey, C P
  organization: University of Bath
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24467517$$D View this record in MEDLINE/PubMed
BookMark eNqNks9u1DAQxi1URLcLB14AWeICh7R2_tjOBalUlCJVggOcLceedF0ldrCdRcuJOxceiGfgIXgSvKRUgISELzPy_PTNfPYcoQPnHSD0kJJjms9JN22OaclIcwetaM1Z0VSCHqAVIYQXlApxiI5ivCYkF3lzDx2Wdc14Q_kKfT6fnU7WOzXgCAPkfGvTDitncLIjfP_0xcAEzoDTgH2Pv33NV36y3hocQMOUfMAGIrhok_2o9lpYJewgbAEnCKPN2hFbh9MG8OjnCHgLLoXcMcHVmNOcqQDqPrrbZxQe3MQ1enf-4u3ZRXH5-uWrs9PLQmdvTVELMC3vBNGgGChhuKKk6hmIruQ9sLLpdCtqLjhjnLa6YVSbDjrOueZaVNUaPVt0p7kbwehlGDkFO6qwk15Z-WfF2Y288ltZl23ZMpoFntwIBP9-hpjkaKOGYVAOsj9JWVu3TPCy_A-0JrUoWXawRo__Qq_9HPaPl6mqbYigOa7R04XSwccYoL-dmxK53waZt0H-3IbMPvrd6C356_szcLIAH-wAu38ryedvLhbJHzjOxnQ
CitedBy_id crossref_primary_10_7554_eLife_81119
crossref_primary_10_1124_mol_119_119321
crossref_primary_10_1016_j_neuropharm_2022_109408
crossref_primary_10_1016_j_neuron_2019_11_016
crossref_primary_10_1038_s41598_017_10360_8
crossref_primary_10_1124_mol_117_109603
crossref_primary_10_1002_pro_3872
crossref_primary_10_1016_j_tins_2024_05_008
crossref_primary_10_1159_000381457
crossref_primary_10_1111_bph_13028
crossref_primary_10_3389_fnmol_2022_919773
crossref_primary_10_1002_mco2_148
crossref_primary_10_1016_j_biopsych_2016_12_022
crossref_primary_10_1016_j_neuroscience_2016_01_047
crossref_primary_10_1016_j_neuroscience_2023_05_026
crossref_primary_10_1016_j_peptides_2016_12_004
crossref_primary_10_3390_cells9112400
crossref_primary_10_7554_eLife_81298
crossref_primary_10_1111_bph_12633
crossref_primary_10_1111_bph_14547
crossref_primary_10_1016_j_pharmthera_2021_107961
Cites_doi 10.1523/JNEUROSCI.4654-10.2011
10.1113/jphysiol.2011.210807
10.1146/annurev.pharmtox.38.1.201
10.1124/mol.106.022376
10.1073/pnas.1105418108
10.1124/mol.104.004747
10.1523/JNEUROSCI.11-08-02574.1991
10.1124/mol.112.081547
10.1124/mol.110.066613
10.1073/pnas.0136822100
10.1523/JNEUROSCI.23-33-10515.2003
10.1038/sj.bjp.0707604
10.1113/jphysiol.1992.sp019136
10.1073/pnas.95.17.9914
10.1046/j.1471-4159.1995.65041636.x
10.1113/jphysiol.2002.023093
10.1523/JNEUROSCI.12-02-00483.1992
10.1111/j.1476-5381.2011.01382.x
10.1038/37610
10.1124/mol.110.069096
10.1073/pnas.1000751107
10.1073/pnas.072075399
10.1523/JNEUROSCI.5251-03.2004
10.1113/jphysiol.2006.117069
10.1523/JNEUROSCI.22-04-01248.2002
10.1016/S0028-3908(02)00061-8
10.1111/j.1476-5381.2009.00140.x
10.1111/ejn.12003
10.1016/j.devcel.2006.04.002
10.1016/0024-3205(81)90148-X
10.1124/mol.58.2.388
10.1523/JNEUROSCI.17-02-00796.1997
10.1124/pr.112.005942
10.1016/j.neuron.2004.12.049
10.1111/j.1476-5381.2010.00872.x
10.1523/JNEUROSCI.1227-12.2012
10.1523/JNEUROSCI.1504-11.2011
10.1111/bph.12447
10.1523/JNEUROSCI.4570-11.2011
10.1523/JNEUROSCI.2304-11.2011
10.1074/jbc.M100305200
10.1523/JNEUROSCI.22-13-05769.2002
10.1016/S0306-4522(96)00444-7
10.1016/0006-8993(94)01391-T
10.1111/bph.12441
10.1124/jpet.110.172643
10.1053/j.gastro.2010.11.005
10.1111/bph.12445
10.1016/j.conb.2011.01.007
10.1074/jbc.M110.177089
10.1016/S1044-7431(03)00173-8
10.1021/bi991205r
10.1111/j.1476-5381.2010.00873.x
ContentType Journal Article
Copyright 2014 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society.
Copyright © 2015 The British Pharmacological Society
Copyright © 2015 The British Pharmacological Society 2015
Copyright_xml – notice: 2014 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society.
– notice: Copyright © 2015 The British Pharmacological Society
– notice: Copyright © 2015 The British Pharmacological Society 2015
DBID 24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7TK
K9.
NAPCQ
7X8
5PM
DOI 10.1111/bph.12605
DatabaseName Wiley Online Library Open Access
Wiley Online Library Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
Neurosciences Abstracts
CrossRef
MEDLINE - Academic

ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1476-5381
EndPage 481
ExternalDocumentID 3534523781
10_1111_bph_12605
24467517
BPH12605
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: MRC project grant
  funderid: G0701486
– fundername: Wellcome Trust Value in People
– fundername: Medical Research Council
  grantid: G0701486
– fundername: Wellcome Trust
GroupedDBID ---
.3N
.55
.GJ
05W
0R~
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
3V.
4.4
52U
52V
53G
5GY
6J9
7RV
7X7
8-0
8-1
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
8UM
A00
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCUV
ABDBF
ABPVW
ABQWH
ABUWG
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFKRA
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
B0M
BAFTC
BAWUL
BBNVY
BENPR
BFHJK
BHBCM
BHPHI
BKEYQ
BMXJE
BPHCQ
BRXPI
BVXVI
C45
CAG
CCPQU
COF
CS3
DCZOG
DIK
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
ECV
EJD
EMB
EMK
EMOBN
ENC
ESX
EX3
F5P
FUBAC
FYUFA
G-S
GODZA
GX1
H.X
HCIFZ
HGLYW
HMCUK
HYE
HZ~
J5H
KBYEO
LATKE
LEEKS
LH4
LITHE
LK8
LOXES
LSO
LUTES
LW6
LYRES
M1P
M7P
MEWTI
MK0
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N9A
NAPCQ
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P4E
PQQKQ
PROAC
PSQYO
Q.N
Q2X
QB0
RIG
ROL
RPM
RWI
SJN
SUPJJ
SV3
TEORI
TR2
TUS
UKHRP
UPT
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WVDHM
WXSBR
X7M
XV2
Y6R
YHG
ZGI
ZXP
ZZTAW
~8M
~S-
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7TK
K9.
7X8
5PM
ID FETCH-LOGICAL-c4765-48ed97b80cea6ea8d7a103f6e8b27fe625bc98478766719c561cdbeb777c7c833
IEDL.DBID RPM
ISSN 0007-1188
IngestDate Tue Sep 17 21:14:24 EDT 2024
Fri Aug 16 01:28:31 EDT 2024
Fri Aug 16 11:39:20 EDT 2024
Thu Oct 10 22:12:26 EDT 2024
Fri Aug 23 01:30:32 EDT 2024
Sat Sep 28 08:13:01 EDT 2024
Sat Aug 24 00:50:51 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords nerve terminal
opioid
PKC
GPCR kinase (GRK)
desensitization
tolerance
morphine
opiate
ventral tegmental area (VTA)
Language English
License Attribution
2014 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4765-48ed97b80cea6ea8d7a103f6e8b27fe625bc98478766719c561cdbeb777c7c833
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292961/
PMID 24467517
PQID 1639508116
PQPubID 42104
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4292961
proquest_miscellaneous_1694968722
proquest_miscellaneous_1640482610
proquest_journals_1639508116
crossref_primary_10_1111_bph_12605
pubmed_primary_24467517
wiley_primary_10_1111_bph_12605_BPH12605
PublicationCentury 2000
PublicationDate January 2015
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – month: 01
  year: 2015
  text: January 2015
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: Oxford, UK
PublicationTitle British journal of pharmacology
PublicationTitleAlternate Br J Pharmacol
PublicationYear 2015
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2006; 70
2004; 66
1987; 32
2010; 107
2013; 65
1991; 11
2002; 13
2013b; 170
2002; 99
2004; 24
2006; 577
2009; 158
1992a; 12
1992b; 450
2000; 58
2002; 42
1995; 65
1997; 17
2011; 21
1997; 390
1998; 95
1998; 54
2008; 153
2011; 286
2011; 164
2010; 78
2012; 82
2002b; 544
2006; 10
2011; 31
2011; 79
1981; 28
2010; 160
1995; 672
2012; 36
2012; 32
2005; 45
2011; 589
2001; 276
1998; 38
2002a; 22
2011; 108
1997; 77
2010; 335
1999; 38
2003; 24
2011; 140
2013; 171
2003; 100
2013a; 170
2003; 23
e_1_2_11_32_1
e_1_2_11_55_1
e_1_2_11_30_1
e_1_2_11_36_1
e_1_2_11_51_1
e_1_2_11_13_1
e_1_2_11_34_1
e_1_2_11_53_1
e_1_2_11_11_1
e_1_2_11_29_1
e_1_2_11_6_1
e_1_2_11_27_1
e_1_2_11_48_1
e_1_2_11_2_1
Christie MJ (e_1_2_11_17_1) 1987; 32
e_1_2_11_20_1
e_1_2_11_45_1
e_1_2_11_47_1
e_1_2_11_24_1
e_1_2_11_41_1
e_1_2_11_8_1
e_1_2_11_43_1
e_1_2_11_15_1
e_1_2_11_38_1
Alvarez VA (e_1_2_11_4_1) 2002; 13
e_1_2_11_19_1
Harris GC (e_1_2_11_22_1) 1991; 11
e_1_2_11_50_1
e_1_2_11_10_1
e_1_2_11_56_1
e_1_2_11_14_1
e_1_2_11_35_1
e_1_2_11_52_1
e_1_2_11_12_1
e_1_2_11_33_1
e_1_2_11_54_1
e_1_2_11_28_1
e_1_2_11_5_1
e_1_2_11_26_1
e_1_2_11_3_1
e_1_2_11_49_1
Bailey CP (e_1_2_11_7_1) 2003; 23
e_1_2_11_21_1
e_1_2_11_44_1
e_1_2_11_46_1
e_1_2_11_25_1
e_1_2_11_40_1
e_1_2_11_9_1
e_1_2_11_23_1
e_1_2_11_42_1
e_1_2_11_18_1
e_1_2_11_16_1
Kovoor A (e_1_2_11_31_1) 1998; 54
e_1_2_11_37_1
e_1_2_11_39_1
References_xml – volume: 77
  start-page: 155
  year: 1997
  end-page: 166
  article-title: A subset of ventral tegmental area neurons is inhibited by dopamine, 5‐hydroxytryptamine and opioids
  publication-title: Neuroscience
– volume: 65
  start-page: 1636
  year: 1995
  end-page: 1645
  article-title: Phosphorylation and agonist‐specific intracellular trafficking of an epitope‐tagged mu‐opioid receptor expressed in HEK 293 cells
  publication-title: J Neurochem
– volume: 23
  start-page: 10515
  year: 2003
  end-page: 10520
  article-title: Mu‐opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine
  publication-title: J Neurosci
– volume: 160
  start-page: 1577
  year: 2010
  end-page: 1579
  article-title: Animal research: Reporting experiments: the ARRIVE guidelines
  publication-title: Br J Pharmacol
– volume: 170
  start-page: 1607
  year: 2013b
  end-page: 1651
  article-title: The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels
  publication-title: Br J Pharmacol
– volume: 450
  start-page: 455
  year: 1992b
  end-page: 468
  article-title: Two types of neurone in the rat ventral tegmental area and their synaptic inputs
  publication-title: J Physiol
– volume: 24
  start-page: 2806
  year: 2004
  end-page: 2812
  article-title: Spinal G‐protein‐gated K + channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia
  publication-title: J Neurosci
– volume: 45
  start-page: 433
  year: 2005
  end-page: 445
  article-title: GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal
  publication-title: Neuron
– volume: 21
  start-page: 275
  year: 2011
  end-page: 282
  article-title: Differential regulation of spontaneous and evoked neurotransmitter release at central synapses
  publication-title: Curr Opin Neurobiol
– volume: 32
  start-page: 633
  year: 1987
  end-page: 638
  article-title: Cellular mechanisms of opioid tolerance: studies in single brain neurons
  publication-title: Mol Pharmacol
– volume: 31
  start-page: 13890
  year: 2011
  end-page: 13896
  article-title: Analgesic tolerance to high‐efficacy agonists but not to morphine is diminished in phosphorylation‐deficient S375A μ‐opioid receptor knock‐in mice
  publication-title: J Neurosci
– volume: 66
  start-page: 1592
  year: 2004
  end-page: 1598
  article-title: Protein kinase C activation enhances morphine‐induced rapid desensitization of mu‐opioid receptors in mature rat locus ceruleus neurons
  publication-title: Mol Pharmacol
– volume: 24
  start-page: 517
  year: 2003
  end-page: 523
  article-title: Two distinct forms of desensitisation of G‐protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide μ‐opioid receptor agonists
  publication-title: Mol Cell Neurosci
– volume: 42
  start-page: 1065
  year: 2002
  end-page: 1078
  article-title: Presynaptic mu‐opioid receptors regulate a late step of the secretory process in rat ventral tegmental area GABAergic neurons
  publication-title: Neuropharmacology
– volume: 31
  start-page: 281
  year: 2011
  end-page: 288
  article-title: Differential expression and sensitivity of presynaptic and postsynaptic opioid receptors regulating hypothalamic proopiomelanocortin neurons
  publication-title: J Neurosci
– volume: 12
  start-page: 483
  year: 1992a
  end-page: 488
  article-title: Opioids excite dopamine neurons by hyperpolarization of local interneurons
  publication-title: J Neurosci
– volume: 28
  start-page: 551
  year: 1981
  end-page: 555
  article-title: Intracranial self‐administration of morphine into the ventral tegmental area in rats
  publication-title: Life Sci
– volume: 140
  start-page: 618
  year: 2011
  end-page: 626
  article-title: Morphine induces μ opioid receptor endocytosis in guinea pig enteric neurons following prolonged receptor activation
  publication-title: Gastroenterology
– volume: 17
  start-page: 796
  year: 1997
  end-page: 803
  article-title: Increased probability of GABA release during withdrawal from morphine
  publication-title: J Neurosci
– volume: 58
  start-page: 388
  year: 2000
  end-page: 398
  article-title: Receptor density and recycling affect the rate of agonist‐induced desensitization of mu‐opioid receptor
  publication-title: Mol Pharmacol
– volume: 107
  start-page: 11608
  year: 2010
  end-page: 11613
  article-title: Ligand‐directed c‐Jun N‐terminal kinase activation disrupts opioid receptor signaling
  publication-title: Proc Natl Acad Sci U S A
– volume: 164
  start-page: 298
  year: 2011
  end-page: 307
  article-title: Agonist‐selective patterns of μ‐opioid receptor phosphorylation revealed by phosphosite‐specific antibodies
  publication-title: Br J Pharmacol
– volume: 31
  start-page: 7811
  year: 2011
  end-page: 7816
  article-title: Nucleus accumbens medium spiny neurons target non‐dopaminergic neurons in the ventral tegmental area
  publication-title: J Neurosci
– volume: 100
  start-page: 271
  year: 2003
  end-page: 276
  article-title: Contribution of GIRK2‐mediated postsynaptic signaling to opiate and alpha 2‐adrenergic analgesia and analgesic sex differences
  publication-title: Proc Natl Acad Sci U S A
– volume: 54
  start-page: 704
  year: 1998
  end-page: 711
  article-title: Agonist induced homologous desensitization of mu‐opioid receptors mediated by G protein‐coupled receptor kinases is dependent on agonist efficacy
  publication-title: Mol Pharmacol
– volume: 589
  start-page: 3775
  year: 2011
  end-page: 3787
  article-title: Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area
  publication-title: J Physiol
– volume: 82
  start-page: 983
  year: 2012
  end-page: 992
  article-title: Morphine desensitization and cellular tolerance are distinguished in rat locus ceruleus neurons
  publication-title: Mol Pharmacol
– volume: 38
  start-page: 201
  year: 1998
  end-page: 207
  article-title: Presynaptic receptors
  publication-title: Annu Rev Pharmacol Toxicol
– volume: 13
  start-page: 5769
  year: 2002
  end-page: 5776
  article-title: mu‐Opioid receptors: ligand‐dependent activation of potassium conductance, desensitization, and internalization
  publication-title: J Neurosci
– volume: 170
  start-page: 1459
  year: 2013a
  end-page: 1581
  article-title: The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
  publication-title: Br J Pharmacol
– volume: 577
  start-page: 907
  year: 2006
  end-page: 924
  article-title: The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?
  publication-title: J Physiol
– volume: 22
  start-page: 1248
  year: 2002a
  end-page: 1255
  article-title: Differential desensitization of responses mediated by presynaptic and postsynaptic A1 adenosine receptors
  publication-title: J Neurosci
– volume: 672
  start-page: 261
  year: 1995
  end-page: 275
  article-title: Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area
  publication-title: Brain Res
– volume: 70
  start-page: 676
  year: 2006
  end-page: 685
  article-title: Agonist‐selective mechanisms of mu‐opioid receptor desensitization in human embryonic kidney 293 cells
  publication-title: Mol Pharmacol
– volume: 10
  start-page: 839
  year: 2006
  end-page: 850
  article-title: Dynasore, a cell‐permeable inhibitor of dynamin
  publication-title: Dev Cell
– volume: 79
  start-page: 768
  year: 2011
  end-page: 775
  article-title: Protein kinase C‐mediated phosphorylation of the μ‐opioid receptor and its effects on receptor signaling
  publication-title: Mol Pharmacol
– volume: 38
  start-page: 14286
  year: 1999
  end-page: 14293
  article-title: Synthesis of a stable form of tertiapin: a high‐affinity inhibitor for inward‐rectifier K+ channels
  publication-title: Biochemistry
– volume: 153
  start-page: S379
  issue: Suppl. 1
  year: 2008
  end-page: S388
  article-title: Agonist‐selective mechanisms of GPCR desensitization
  publication-title: Br J Pharmacol
– volume: 171
  start-page: 253
  year: 2013
  end-page: 264
  article-title: G protein‐gated inwardly rectifying potassium (GIRK) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites
  publication-title: Br J Pharmacol
– volume: 335
  start-page: 674
  year: 2010
  end-page: 680
  article-title: Tolerance to the antinociceptive effect of morphine in the absence of short‐term presynaptic desensitization in rat periaqueductal gray neurons
  publication-title: J Pharmacol Exp Ther
– volume: 99
  start-page: 4674
  year: 2002
  end-page: 4679
  article-title: Desensitization of mu‐opioid receptor‐evoked potassium currents: initiation at the receptor, expression at the effector
  publication-title: Proc Natl Acad Sci U S A
– volume: 390
  start-page: 611
  year: 1997
  end-page: 614
  article-title: How opioids inhibit GABA‐mediated neurotransmission
  publication-title: Nature
– volume: 65
  start-page: 223
  year: 2013
  end-page: 254
  article-title: Regulation of μ‐opioid receptors: desensitization, phosphorylation, internalization, and tolerance
  publication-title: Pharmacol Rev
– volume: 108
  start-page: 16446
  year: 2011
  end-page: 16450
  article-title: Neuronal circuits underlying acute morphine action on dopamine neurons
  publication-title: Proc Natl Acad Sci U S A
– volume: 36
  start-page: 3636
  year: 2012
  end-page: 3642
  article-title: μ‐Opioid receptor desensitization: homologous or heterologous?
  publication-title: Eur J Neurosci
– volume: 286
  start-page: 12724
  year: 2011
  end-page: 12733
  article-title: Modulating micro‐opioid receptor phosphorylation switches agonist‐dependent signaling as reflected in PKCepsilon activation and dendritic spine stability
  publication-title: J Biol Chem
– volume: 276
  start-page: 31408
  year: 2001
  end-page: 31414
  article-title: C‐terminal splice variants of the mouse mu‐opioid receptor differ in morphine‐induced internalization and receptor resensitization
  publication-title: J Biol Chem
– volume: 32
  start-page: 10192
  year: 2012
  end-page: 10200
  article-title: Multiple inhibitory G‐protein‐coupled receptors resist acute desensitization in the presynaptic but not postsynaptic compartments of neurons
  publication-title: J Neurosci
– volume: 31
  start-page: 17729
  year: 2011
  end-page: 17735
  article-title: Opioid‐sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons
  publication-title: J Neurosci
– volume: 78
  start-page: 756
  year: 2010
  end-page: 766
  article-title: μ‐opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization
  publication-title: Mol Pharmacol
– volume: 95
  start-page: 9914
  year: 1998
  end-page: 9919
  article-title: Morphine‐activated opioid receptors elude desensitization by beta‐arrestin
  publication-title: Proc Natl Acad Sci U S A
– volume: 158
  start-page: 157
  year: 2009
  end-page: 164
  article-title: Involvement of PKC alpha and G‐protein‐coupled receptor kinase 2 in agonist‐selective desensitization of mu‐opioid receptors in mature brain neurons
  publication-title: Br J Pharmacol
– volume: 544
  start-page: 459
  year: 2002b
  end-page: 467
  article-title: GABA(B) receptor activation desensitizes postsynaptic GABA(B) and A(1) adenosine responses in rat hippocampal neurones
  publication-title: J Physiol
– volume: 160
  start-page: 1573
  year: 2010
  end-page: 1576
  article-title: Guidelines for reporting experiments involving animals: the ARRIVE guidelines
  publication-title: Br J Pharmacol
– volume: 11
  start-page: 2574
  year: 1991
  end-page: 2581
  article-title: Transient homologous mu‐opioid receptor desensitization in rat locus coeruleus neurons
  publication-title: J Neurosci
– ident: e_1_2_11_47_1
  doi: 10.1523/JNEUROSCI.4654-10.2011
– ident: e_1_2_11_16_1
  doi: 10.1113/jphysiol.2011.210807
– ident: e_1_2_11_42_1
  doi: 10.1146/annurev.pharmtox.38.1.201
– ident: e_1_2_11_25_1
  doi: 10.1124/mol.106.022376
– ident: e_1_2_11_23_1
  doi: 10.1073/pnas.1105418108
– ident: e_1_2_11_8_1
  doi: 10.1124/mol.104.004747
– volume: 11
  start-page: 2574
  year: 1991
  ident: e_1_2_11_22_1
  article-title: Transient homologous mu‐opioid receptor desensitization in rat locus coeruleus neurons
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.11-08-02574.1991
  contributor:
    fullname: Harris GC
– ident: e_1_2_11_33_1
  doi: 10.1124/mol.112.081547
– ident: e_1_2_11_40_1
  doi: 10.1124/mol.110.066613
– ident: e_1_2_11_43_1
  doi: 10.1073/pnas.0136822100
– volume: 23
  start-page: 10515
  year: 2003
  ident: e_1_2_11_7_1
  article-title: Mu‐opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-33-10515.2003
  contributor:
    fullname: Bailey CP
– ident: e_1_2_11_28_1
  doi: 10.1038/sj.bjp.0707604
– ident: e_1_2_11_27_1
  doi: 10.1113/jphysiol.1992.sp019136
– ident: e_1_2_11_53_1
  doi: 10.1073/pnas.95.17.9914
– ident: e_1_2_11_5_1
  doi: 10.1046/j.1471-4159.1995.65041636.x
– ident: e_1_2_11_52_1
  doi: 10.1113/jphysiol.2002.023093
– ident: e_1_2_11_26_1
  doi: 10.1523/JNEUROSCI.12-02-00483.1992
– ident: e_1_2_11_18_1
  doi: 10.1111/j.1476-5381.2011.01382.x
– ident: e_1_2_11_50_1
  doi: 10.1038/37610
– ident: e_1_2_11_19_1
  doi: 10.1124/mol.110.069096
– ident: e_1_2_11_41_1
  doi: 10.1073/pnas.1000751107
– volume: 54
  start-page: 704
  year: 1998
  ident: e_1_2_11_31_1
  article-title: Agonist induced homologous desensitization of mu‐opioid receptors mediated by G protein‐coupled receptor kinases is dependent on agonist efficacy
  publication-title: Mol Pharmacol
  contributor:
    fullname: Kovoor A
– ident: e_1_2_11_11_1
  doi: 10.1073/pnas.072075399
– ident: e_1_2_11_38_1
  doi: 10.1523/JNEUROSCI.5251-03.2004
– ident: e_1_2_11_37_1
  doi: 10.1113/jphysiol.2006.117069
– ident: e_1_2_11_51_1
  doi: 10.1523/JNEUROSCI.22-04-01248.2002
– ident: e_1_2_11_10_1
  doi: 10.1016/S0028-3908(02)00061-8
– ident: e_1_2_11_9_1
  doi: 10.1111/j.1476-5381.2009.00140.x
– ident: e_1_2_11_34_1
  doi: 10.1111/ejn.12003
– ident: e_1_2_11_36_1
  doi: 10.1016/j.devcel.2006.04.002
– ident: e_1_2_11_14_1
  doi: 10.1016/0024-3205(81)90148-X
– ident: e_1_2_11_32_1
  doi: 10.1124/mol.58.2.388
– volume: 32
  start-page: 633
  year: 1987
  ident: e_1_2_11_17_1
  article-title: Cellular mechanisms of opioid tolerance: studies in single brain neurons
  publication-title: Mol Pharmacol
  contributor:
    fullname: Christie MJ
– ident: e_1_2_11_13_1
  doi: 10.1523/JNEUROSCI.17-02-00796.1997
– ident: e_1_2_11_54_1
  doi: 10.1124/pr.112.005942
– ident: e_1_2_11_6_1
  doi: 10.1016/j.neuron.2004.12.049
– ident: e_1_2_11_29_1
  doi: 10.1111/j.1476-5381.2010.00872.x
– ident: e_1_2_11_46_1
  doi: 10.1523/JNEUROSCI.1227-12.2012
– ident: e_1_2_11_55_1
  doi: 10.1523/JNEUROSCI.1504-11.2011
– ident: e_1_2_11_3_1
  doi: 10.1111/bph.12447
– ident: e_1_2_11_39_1
  doi: 10.1523/JNEUROSCI.4570-11.2011
– ident: e_1_2_11_21_1
  doi: 10.1523/JNEUROSCI.2304-11.2011
– ident: e_1_2_11_30_1
  doi: 10.1074/jbc.M100305200
– volume: 13
  start-page: 5769
  year: 2002
  ident: e_1_2_11_4_1
  article-title: mu‐Opioid receptors: ligand‐dependent activation of potassium conductance, desensitization, and internalization
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-13-05769.2002
  contributor:
    fullname: Alvarez VA
– ident: e_1_2_11_15_1
  doi: 10.1016/S0306-4522(96)00444-7
– ident: e_1_2_11_49_1
  doi: 10.1016/0006-8993(94)01391-T
– ident: e_1_2_11_44_1
  doi: 10.1111/bph.12441
– ident: e_1_2_11_20_1
  doi: 10.1124/jpet.110.172643
– ident: e_1_2_11_45_1
  doi: 10.1053/j.gastro.2010.11.005
– ident: e_1_2_11_2_1
  doi: 10.1111/bph.12445
– ident: e_1_2_11_48_1
  doi: 10.1016/j.conb.2011.01.007
– ident: e_1_2_11_56_1
  doi: 10.1074/jbc.M110.177089
– ident: e_1_2_11_12_1
  doi: 10.1016/S1044-7431(03)00173-8
– ident: e_1_2_11_24_1
  doi: 10.1021/bi991205r
– ident: e_1_2_11_35_1
  doi: 10.1111/j.1476-5381.2010.00873.x
SSID ssj0014775
Score 2.3040342
Snippet Background and Purpose The majority of studies examining desensitization of the μ‐opioid receptor (MOR) have examined those located at cell bodies. However,...
The majority of studies examining desensitization of the μ-opioid receptor (MOR) have examined those located at cell bodies. However, MORs are extensively...
Background and Purpose The majority of studies examining desensitization of the μ‐opioid receptor ( MOR ) have examined those located at cell bodies. However,...
Background and Purpose The majority of studies examining desensitization of the µ-opioid receptor (MOR) have examined those located at cell bodies. However,...
BACKGROUND AND PURPOSEThe majority of studies examining desensitization of the μ-opioid receptor (MOR) have examined those located at cell bodies. However,...
Background and Purpose The majority of studies examining desensitization of the mu -opioid receptor (MOR) have examined those located at cell bodies. However,...
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 469
SubjectTerms Action Potentials
Analgesics, Opioid - pharmacology
Animals
desensitization
Dopaminergic Neurons - drug effects
Dopaminergic Neurons - physiology
Enkephalin, Ala-MePhe-Gly- - pharmacology
Enkephalin, Methionine - pharmacology
GABAergic Neurons - drug effects
GABAergic Neurons - physiology
GPCR kinase (GRK)
In Vitro Techniques
Male
Mice, Inbred C57BL
morphine
Morphine - pharmacology
nerve terminal
opiate
opioid
PKC
Protein Kinase C - physiology
Receptors, Opioid, mu - agonists
Receptors, Opioid, mu - physiology
Themed Section: Opioids: New Pathways to Functional Selectivity
tolerance
ventral tegmental area (VTA)
Ventral Tegmental Area - physiology
SummonAdditionalLinks – databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwEB6VcuGCyn_aggaEKg4N2mQd2xEnQKxWHNAeWqm3yHZm6UpVdkWWSr313gsPxDPwEDwJYztJu6pA3KLYkWKNx_ONPf4-gNeGo6Qe8eTlaEGp0M6mRpWUkrW2MMLktQtsn1_k9Fh8PilOtuBdfxcm8kMMG27eM8J67R3c2PaGk9vV6dvMo_E7cNczxvh6vlzMhiMEoVSUL_AsiJnWHa2QL-MZPt0MRrcQ5u1CyZsANkSgyQ7c76Ajvo-2fgBb1DyEg1nknr44xKPrq1TtIR7g7JqV-uIRXE04gsWNP2yD-E2QjUDT1OgF5n9f_ugFcR3hco6_fvKr5WqxXNTIyyKtODvH2l9W8mVe8fYmmjU2vmYSu6KasxYXDTKoRL-lQHgeh8TNX6OKABpGqY_hePLp6OM07ZQYUieULNiGVJfK6pEjI8noWplsNJ5L0jZXc-IcyrpSe54fKVVWOgZlrrZklVJOOT0eP4HtZtnQM0A2FWd4RvNUYDDEgEHYfDwvC005MZSkBF71JqlWkXCj6hMVtlsV7JbAfm-sqvO5tmJk6SVts0wm8HJoZm_xRyCmIR429xG8ZHHWOPpXn1KUUqs8T-BptP_wJwyGOMPKVAJqY2YMHTxb92ZLszgNrN1eF6yUWQJvwhz6--CqD7NpeNj9_657cI-RXBH3hvZhe_3tOz1ntLS2L4JX_AEcTxcm
  priority: 102
  providerName: Wiley-Blackwell
Title Functional selectivity and time‐dependence of μ‐opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbph.12605
https://www.ncbi.nlm.nih.gov/pubmed/24467517
https://www.proquest.com/docview/1639508116
https://search.proquest.com/docview/1640482610
https://search.proquest.com/docview/1694968722
https://pubmed.ncbi.nlm.nih.gov/PMC4292961
Volume 172
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEB6yOfUSmv6kTtMwLSH0EO-uvbYlH9vQ7VJo8CGBvRlJnm0Midd0N4U8QV-qz9Bn6kiyNwmhPfRiDBLYYkaab6TR9wEcKY6ScszOy9GCwkQaHSqRU0ha61QlKq6MY_s8y2YXyZd5Ot-CtL8L44r2ja6HzdX1sKkvXW1le21GfZ3YqPh6aiWW8iwaDWDADtqn6N3RQSKEly2w7IeRlB2dkC3f0e3lMLIA3lIAcx4kUqdTdi8ePQKZj2sl72NYF4SmT2GnQ4_4wf_lLmxR8wyOC08_fXuC53e3qVYneIzFHTH17XP4OeUg5vf-cOX0b5xyBKqmQqsxH_aKuIZwucDfv8JlWy_rCnlVpJaTc6zsXSVb5eUvb6JaY2NLJrGrqblaYd0gY0q0OwqEP_xwuPmbFxFAxSD1BVxMP52fzsJOiCE0ichSNiFVudBybEhlpGQlVDSeLDKSOhYL4hRKm1xamp8sE1FuGJOZSpMWQhhh5GTyErabZUOvABmAcoKnJHsCYyHGC4mOJ4s8lRQTI0kK4F1vjrL1fBtln6ew-UpnvgAOekOV3ZRblQwsraJtFGUBvN0082SxJyCqIR4290l4xeKkcfyvPnmSZ1LEcQB73vabP-mdJgDxwCs2HSxZ98MW9mFH2t35bADvnf_8fXDlx2LmXvb_-yOv4QnjutTvFB3A9vr7Db1h7LTWhzCIk4Kfn-fRoZs3fwAxqR5j
link.rule.ids 230,315,730,783,787,888,11575,27937,27938,46065,46489,53805,53807
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL0qZQEb3o9AgQtCFYsmk2SS2FlCxWiAtprFFHUX2Y6HRrSZiJkilR_gp_gGvolrO562VCDBLpItJU6Oc8-1r88BeCkoSvKYwEvRQocZVzIUrNShllLmIhNpraza514x3s_eH-QHa5D7szC2aF_JJmqPjqO2ObS1ld2xGvg6scFkd9tYLJVFMrgCV2m-xrlP0vvNg4wxZ1xg9A8TzntBIVPAI7vDKDEU3ogAUybEcutUdi4iXaKZl6slz7NYG4ZGN-GjH4CrPvkcnSxlpL79pu34zyO8BTd6YoqvXfNtWNPtHdicOGXr0y2cnh3UWmzhJk7ONK9P78L3EcVHt6yIC2utY00pULQ1Gvv60JvtKo3zGf78Ec67Zt7USD9c3VHej7U5BmUKyNy5UBRLbE01JvblOkcLbFokuopmsULjV_eeqPmT8ydAQfz3HuyP3k63x2Hv8RCqjBU5oUPXJZM8VloUWvCaiSQezgrNZcpmmrIzqUpuFISKgiWlIrqnaqklY0wxxYfD-7Dezlv9EJC4LeWOghPIiGYRFclkOpyVOdepJpKqA3jhv3PVOSmPyqdAhIvK4iKADY-Aqp_Ni4o4qzHLTZIigOerZpqHZnNFtJqGTX0y-hlSPhr_rU-ZlQVnaRrAAweq1ZN4NAbALsBt1cHogF9sIfBYPfAeLAG8ssD88-CqN5OxvXj03zd5BtfG092daufd3ofHcJ3oY-4WpDZgffnlRD8hiraUT-2E_AW3VT6T
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2CIiE25U0DLVwQqlg0mUkmiZ1lKYyGV5VFK1VsIttxaNQ2E3WmSOUH-Cm-gW_i2k6mUypYdBfJlhInx7nn2tfnALwWFCX5kMBL0UL7MVfSFyzTvpZSJiIWUams2uduOtmPPx4kB0tWX7ZoX8k6aI5PgqY-tLWV7Yka9HVig_zLjrFYytJw0JbV4CbcSoxoep-odxsIMWPOvMBoIIacd6JCpohHtodBaGi8EQKmbIgl1q1sKSpdoZpXKyaXmawNReO78LUfhKtAOQrO5jJQP_7Sd7zWKO_BakdQcdt1uQ83dPMANnOncH2-hXsXB7ZmW7iJ-YX29flD-DmmOOmWF3FmLXasOQWKpkRjY-_3prtK47TC37_8aVtP6xLpx6tbyv-xNMehTCGZOx-KYo6NqcrErmzneIZ1g0Rb0SxaaPzu3hU1f3M-BSiIBz-C_fH7vZ2J33k9-CpmaUIo0WXGJB8qLVIteMlEOBxVqeYyYpWmLE2qjBsloTRlYaaI9qlSaskYU0zx0egxrDTTRq8BEselHFJwAhvRLaIksYxGVZZwHWkiq9qDV_23Llon6VH0qRBho7DY8GC9R0HRzepZQdzVmOaGYerBy0UzzUezySIaTcOmPjH9FCkvHf6vTxZnKWdR5METB6zFk_SI9IBdgtyig9EDv9xCALK64B1gPHhjwfnvwRVv84m9eHrtm7yA2_m7cfH5w-6nZ3CHWGTi1qXWYWV-eqY3iKnN5XM7J_8Ahd9BEw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+selectivity+and+time-dependence+of+%CE%BC-opioid+receptor+desensitization+at+nerve+terminals+in+the+mouse+ventral+tegmental+area&rft.jtitle=British+journal+of+pharmacology&rft.au=Lowe%2C+J+D&rft.au=Bailey%2C+C+P&rft.date=2015-01-01&rft.eissn=1476-5381&rft.volume=172&rft.issue=2&rft.spage=469&rft.epage=481&rft_id=info:doi/10.1111%2Fbph.12605&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon